Foreign drug manufacturers call for simpler price assessment procedures over new drugs

Published: 2009-04-20 07:00:00

Updated: 2009-04-20 07:00:00

Representatives from the Korean Research-based Pharmaceutical Industry Association (KRPIA) said on April 15 that the Korean government will have to overhaul the current positive list system by incorporating the screening process of new drugs eligible for national health insurance reimbursement wi...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK